Continuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial

  • Baran Balcan, Erik Thunström, Patrick J. Strollo Jr., Yüksel Peker
  • Annals of the American Thoracic Society, January 2019, American Thoracic Society
  • DOI: 10.1513/annalsats.201803-174oc

Continuous Positive Airway Pressure Treatment and Depression in Coronary Artery Disease with OSA

What is it about?

This study evaluated the effect of CPAP on depressive mood in the same cohort as one of the secondary outcomes of the RICCADSA trial

Why is it important?

This is the first randomized controlled trial in the literature that evaluated the impact of positive airway treatment on depression in coronary artery disease patients with obstructive sleep apnea.

Read Publication

http://dx.doi.org/10.1513/annalsats.201803-174oc

The following have contributed to this page: dr Baran Balcan and Prof. Dr Yuksel Peker